We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
AGI | LSE:AGI | London | Ordinary Share | IE00B0YT0Q82 | ORD EUR0.01 |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 7.25 | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
TIDMAGI
RNS Number : 6018V
AGI Therapeutics plc
16 January 2012
FORM 8.3 IRISH TAKEOVER PANEL DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2007 (AS AMENDED) DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE 1. KEY INFORMATION ================================================================ Name of person dealing Paul Johnson (Note 1) ============================ ================================== Company dealt in AGI Therapeutics plc ============================ ================================== Class of relevant security Ordinary Shares EUR0.01 to which the dealings each being disclosed relate (Note 2) ============================ ================================== Date of dealing 13.1.12 ============================ ================================== 2. INTERESTS AND SHORT POSITIONS (a) Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3) ================================================================ Long Short ============================ =============== ================= Number (%) Number (%) ============================ =============== ================= (1) Relevant securities 524,715 ============================ =============== ================= (2) Derivatives (other than options) ============================ =============== ================= (3) Options and agreements to purchase/sell ============================ =============== ================= Total ============================ =============== ================= (b) Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3) ================================================================ Class of relevant security: Long Short ============================ =============== ================= Number (%) Number (%) ============================ =============== ================= (1) Relevant securities ============================ =============== ================= (2) Derivatives (other than options) ============================ =============== ================= (3) Options and agreements to purchase/sell ============================ =============== ================= Total ============================ =============== ================= 1 February 2009 3. DEALINGS (Note 4) (a) Purchases and sales ================================================================================================================ Purchase/sale Number of relevant securities Price per unit (Note 5) ============================ =================================================== ============================= s Sale 254,067 GBP0.0706 Sale 250,000 GBP0.0707 ============================ =================================================== ============================= (b) Derivatives transactions (other than options transactions) ================================================================================================================ Product name, e.g. Nature of transaction Number of relevant Price per CFD securities unit (Note 6) (Note 7) (Note 5) ================== =============================== ======================================== ================= (c) Options transactions in respect of existing relevant securities (i) Writing, selling, purchasing or varying ================================================================================================================ Product Writing, Number of Exercise Type, Expiry Option name, e.g. selling, securities price e.g. American, date money call option purchasing, to which European paid/received varying the option etc. per unit etc. relates (Note (Note 7) 5) ============ ======================= ================ =========== ================= ======== ============= (ii) Exercising ================================================================================================================ Product name, Number of securities Exercise price e.g. call option per unit (Note 5) ============================ =================================================== ============================= (d) Other dealings (including transactions in respect of new securities) (Note 4) ================================================================================================================ Nature of transaction Details Price per unit (Note 8) (if applicable) (Note 5) ============================ =================================================== ============================= 1 February 2009 4. OTHER INFORMATION Agreements, arrangements or understandings relating to options or derivatives ======================================================== Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated. ======================================================== Is a Supplemental Form 8 attached? (Note 9) NO ======================================================== Date of disclosure 13.1.12 ================================= ===================== Contact name Paul Johnson ================================= ===================== Telephone number +44 (0) 1276 500618 ================================= ===================== If a connected EFM, name of offeree/offeror with which connected ================================= ===================== If a connected EFM, state nature of connection (Note 10) ================================= ===================== 1 February 2009
This information is provided by RNS
The company news service from the London Stock Exchange
END
RETUNUKRUUAAARR
1 Year AGI Chart |
1 Month AGI Chart |
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions